ProShare Advisors’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$68.4K Buy
+10,888
New +$77.8K ﹤0.01% 1744
2026
Q1
– Sell
-10,830
Closed -$59K – 1879
2025
Q4
$59K Buy
+10,830
New +$64.3K ﹤0.01% 1938
2025
Q3
– Sell
-10,003
Closed -$62.6K – 2014
2025
Q2
$62.6K Sell
10,003
-2,290
-19% -$13.4K ﹤0.01% 1967
2025
Q1
$72K Sell
12,293
-3,134
-20% -$23.7K ﹤0.01% 1896
2024
Q4
$127K Buy
+15,427
New +$145K ﹤0.01% 2019

Other funds holding AURA

ProShare Advisors's AURA Position: Q3 2026 in Review

ProShare Advisors opened a new position in Aura Biosciences (AURA) in Q3 2026: 10,888 shares worth $68.4K. The stake represents ﹤0.01% of the portfolio and ranks #1744 among its holdings. This is a return to the name: ProShare Advisors previously reported a position in AURA as recently as Q4 2025.

ProShare Advisors first reported a position in AURA in Q4 2024 and has held it in 5 quarters since. The position peaked at $127K in Q4 2024. 26 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • ProShare Advisors held 10,888 shares of Aura Biosciences worth $68.4K as of Q3 2026.
  • Aura Biosciences was a new ProShare Advisors position in Q3 2026.
  • Aura Biosciences made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #1744 holding.
  • ProShare Advisors first reported a position in Aura Biosciences in Q4 2024 and has held it in 5 quarters since.
  • ProShare Advisors's Aura Biosciences position peaked at $127K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.